Organization
Ligand Pharmaceuticals, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Ligand Pharmaceuticals, Inc.
... an Analyst Day event held today in New York City, Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) reviewed the recent progress of its business, including its revenue ...
... Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported financial results for the three and nine months ...
... Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) will host an Analyst Day on Tuesday, November 14, 2017 ...
... Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces that the company is scheduled to participate in the ...
... Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced today that it plans to report third quarter 2017 ...
... Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) and Crystal Bioscience, Inc. (Crystal) announce the signing of a ...
... Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) will host an Analyst Day on Tuesday, November 14, 2017 ...
... treatment of hip and other fracture patients: Keith Marschke, Ph.D., VP, Biology, Ligand PharmaceuticalsJay Magaziner, Ph.D., Epidemiology and Biostatistics Professor and Chair, Department of Epidemiology ...
... SAN DIEGO - Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced positive top-line results from a Phase 2 clinical ...
... Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced positive top-line results from a Phase 2 clinical ...
... Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces that company executives are scheduled to participate in the ...
... Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) ("Ligand" or "the Company") announces the appointment of Nancy Ryan ...
... Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) ("Ligand" or "the Company") announces that it will receive a ...
... SAN DIEGO - Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported financial results for the three and six months ...
... Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported financial results for the three and six months ...
... LakePharma), Debra Valsamis (Business Development Associate, Antibody Solutions), Christel Iffland (Vice President, Ligand Pharmaceuticals), Ignacio Pino (President and CEO, CDI Laboratories), Jeng Her (CEO, AP ...
... Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced today plans to report second quarter 2017 financial results ...
... Research, in charge of the new recruitment push. FDA Voice post > Ligand Pharmaceuticals has penned an updated commercial license and supply agreement with Amgen, ...
... Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced that it has entered into a commercial license ...
... Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces it has entered into a worldwide license agreement with ...
... Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces it will receive $10 million from a contractually specified ...
... Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) announces it has entered into a worldwide license agreement with ...
... Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces that company executives are scheduled to participate in the ...
Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!
Start My Free Trial ➤